by Team PCM | May 31, 2024 | Newsletter
NEW BLOG How GLP-1s Impact Healthcare Benefits for Self-Insured Employers The evolution of GLP-1s brings opportunities and challenges for self-insured plans, influencing overall healthcare spending and necessitating strategic adjustments in formulary development. Read...
by Team PCM | Apr 25, 2024 | Newsletter
Catch up on our latest Webinar: Preparing Self-Funded Plans for the Game-Changing Impact of Biosimilars Featuring PCM’s Chief Pharmacist, Dr. David Merritt PharmD, RPh, who takes a closer look at how biosimilar adoption will affect plan and patient costs, breaking...
by Team PCM | Mar 28, 2024 | Newsletter
NEW BLOG The Impact of Biosimilars and Generic Alternatives on Specialty Management As healthcare plans adapt to the evolving landscape, they are implementing strategies to effectively manage biosimilars and generic alternatives, thereby benefiting patients and...
by Team PCM | Feb 29, 2024 | Newsletter
NEW BLOG Contract and Claim Analysis: Helping Fiduciaries Manage Plan Assets Appropriately At the most basic level, many benefits experts claim to meet fiduciary duties by comparing a plan’s pharmacy contract to a handful of similar programs. A more thorough contract...
by Team PCM | Jan 25, 2024 | Newsletter
NEW BLOG 2024 Will See Higher than Normal Employer Health Cost Increases – What Actions Can You Take to Control Costs? The numbers change, but the one thing that remains constant is that health costs increase every year. Read more. INDUSTRY NEWS FDA says Florida can...
by Team PCM | Dec 21, 2023 | Newsletter
Happy Holidays, From day one, our mission has been to provide our partners with the information and support they need to make highly informed plan decisions. In the new year, we anticipate releasing exciting new features on our analytics platform and several...